0001209191-17-022141.txt : 20170321
0001209191-17-022141.hdr.sgml : 20170321
20170321200952
ACCESSION NUMBER: 0001209191-17-022141
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170320
FILED AS OF DATE: 20170321
DATE AS OF CHANGE: 20170321
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cascadian Therapeutics, Inc.
CENTRAL INDEX KEY: 0001412067
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 260868560
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2601 FOURTH AVENUE
STREET 2: SUITE 500
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: (206) 801-2100
MAIL ADDRESS:
STREET 1: 2601 FOURTH AVENUE
STREET 2: SUITE 500
CITY: SEATTLE
STATE: WA
ZIP: 98121
FORMER COMPANY:
FORMER CONFORMED NAME: Oncothyreon Inc.
DATE OF NAME CHANGE: 20070927
FORMER COMPANY:
FORMER CONFORMED NAME: Biomira CORP
DATE OF NAME CHANGE: 20070911
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Myers Scott Dunseth
CENTRAL INDEX KEY: 0001356256
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33882
FILM NUMBER: 17705333
MAIL ADDRESS:
STREET 1: C/O ONOTHYREON INC.
STREET 2: 2601 4TH AVENUE, SUITE 500
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-03-20
0
0001412067
Cascadian Therapeutics, Inc.
CASC
0001356256
Myers Scott Dunseth
C/O CASCADIAN THERAPEUTICS, INC.
2601 4TH AVE., SUITE 500
SEATTLE
WA
98121
1
1
0
0
President and CEO
Common Stock
2017-03-20
4
P
0
1000
3.9271
A
39416
D
/s/ Julia M. Eastland as attorney-in-fact for Scott D. Myers
2017-03-21